Advanced Medical Solutions Group (LSE:AMS) ROCE %: 6.61% (As of Dec. 2025)


LSE:AMS Advanced Medical Solutions Group PLC LSE:AMS
89 GF Score
Price £2.79
GF Value £3.69
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group ROCE %?

Advanced Medical Solutions Group LSE:AMS +16.04% 89 ROCE % is 6.61% as of Dec. 2025. GuruFocus rates LSE:AMS with a GF Score™ of 89/100 and a GF Value™ of £3.69 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Advanced Medical Solutions Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.61%.

Advanced Medical Solutions Group  (LSE:AMS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Advanced Medical Solutions Group ROCE % Related Terms

Advanced Medical Solutions Group ROCE % Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group ROCE % Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.80 10.70 8.19 4.32 6.56

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.64 3.91 4.22 6.38 6.61
LSE:AMS
89GF Score
Advanced Medical Solutions Group PLC LSE:AMS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group ROCE % Calculation

Advanced Medical Solutions Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=22.586/( ( (388.496 - 44.331) + (394.77 - 49.946) )/ 2 )
=22.586/( (344.165+344.824)/ 2 )
=22.586/344.4945
=6.56 %

Advanced Medical Solutions Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=23.002/( ( (397.436 - 46.72) + (394.77 - 49.946) )/ 2 )
=23.002/( ( 350.716 + 344.824 )/ 2 )
=23.002/347.77
=6.61 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.61% mean?
Advanced Medical Solutions Group (LSE:AMS) has a ROCE % of 6.61% as of Dec. 2025.
Is Advanced Medical Solutions Group's ROCE % too high?
Advanced Medical Solutions Group's current ROCE % is 6.61%. The Medical Devices & Instruments industry median ROCE % is 2.23. Advanced Medical Solutions Group's value of 6.61% is 196.4% above this industry median. Overall, Advanced Medical Solutions Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's ROCE % compare to ISRG and BDX?
Advanced Medical Solutions Group's ROCE % of 6.61% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Advanced Medical Solutions Group's value of 6.61% is 196.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current ROCE % of 6.61% is 196.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current ROCE % is 6.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (LSE:AMS) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.69, compared to a current price of £2.79 — trading 24.5% below its estimated fair value. The current ROCE % is 6.61% and 196.4% above the Medical Devices & Instruments industry median of 2.23. Advanced Medical Solutions Group's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Advanced Medical Solutions Group (LSE:AMS), the current ROCE % is 6.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (LSE:AMS) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.79 is trading 24.5% below its estimated GF Value™ of £3.69. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for LSE:AMS:

  • ROCE %: 6.61%
  • GF Value™: £3.69 vs. price of £2.79 (24.5% below fair value)
  • GF Score™: 89/100 with 6 warning signs
  • Industry Position: 196.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the LSE:AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advanced Medical Solutions Group Business Description

Other Exchanges AMSl:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
89GF Score

Get the complete analysis for LSE:AMS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.79
Price
£3.69
GF Value